Berkshire Hathaway Inc sold $69.0M of DaVita (DVA)

Executed Oct 27, disclosed Oct 29, 2 days later.

Value, as filed

$69.0M

382,563 sh × $180.43

Executed

Oct 27

the trade date, as filed

Disclosed

Oct 29

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BI Berkshire Hathaway Inc 10% owner profile →

Berkshire Hathaway Inc (10% owner) filed 9 Form 4 reports as a reporting entity in the trailing twelve months (5 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in DaVita Inc. (DVA). Across 4 priced purchase filings, the average 21-session return was +0.5% from execution and +4.9% from disclosure (delay-adjusted; derived). The largest single filing was $212.3M of LEN (2,741,929 sh across 13 lots, as filed), executed Sep 17.

The name

DVA

DaVita Inc. DVA · Healthcare · 20 filings in 24 months ticker →

Healthcare · DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Berkshire Hathaway Inc in DVA

DVASALE DaVita Inc. $36.5M
182,980 sh × $199.55
Exec Jul 31
Filed Aug 4 · 5:27 PM ET DVASALE DaVita Inc. $182.9M
1,220,376 sh × $149.84
Exec May 1
Filed May 5 · 5:30 PM ET DVASALE DaVita Inc. $54.3M
401,514 sh × $135.36
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET DVASALE DaVita Inc. $230.0M
1,635,962 sh × $140.61
Exec Jul 31 2025
Filed Aug 4 2025 · 5:30 PM ET DVASALE DaVita Inc. $168.6M
1,145,938 sh × $147.11
Exec May 8 2025
Filed May 12 2025 · 5:30 PM ET DVASALE DaVita Inc. $31.7M
203,091 sh × $156.01
Exec Feb 11 2025
Filed Feb 13 2025 · 5:30 PM ET